vs
TG THERAPEUTICS, INC.（TGTX）与世纪互联（VNET）财务数据对比。点击上方公司名可切换其他公司
世纪互联的季度营收约是TG THERAPEUTICS, INC.的1.9倍（$362.7M vs $192.6M），TG THERAPEUTICS, INC.净利率更高（12.0% vs -10.7%，领先22.6%），TG THERAPEUTICS, INC.自由现金流更多（$19.6M vs $-193.1M），过去两年TG THERAPEUTICS, INC.的营收复合增速更高（74.2% vs 17.4%）
TG Therapeutics是一家处于商业化阶段的生物制药企业，专注于开发及商业化B细胞恶性肿瘤、自身免疫性疾病与神经退行性疾病的创新疗法，核心产品线覆盖靶向单克隆抗体与口服小分子药物，主要市场为北美和欧洲。
VNET Group即世纪互联，是中国领先的第三方中立数据中心服务商，提供机柜托管、云基础设施、混合云部署及网络管理等解决方案，服务覆盖科技、金融、零售等多领域企业客户，为企业数字化运营提供稳定的算力与网络支撑。
TGTX vs VNET — 直观对比
营收规模更大
VNET
是对方的1.9倍
$192.6M
净利率更高
TGTX
高出22.6%
-10.7%
自由现金流更多
TGTX
多$212.7M
$-193.1M
两年增速更快
TGTX
近两年复合增速
17.4%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $192.6M | $362.7M |
| 净利润 | $23.0M | $-38.7M |
| 毛利率 | 80.2% | 20.9% |
| 营业利润率 | 26.2% | 0.5% |
| 净利率 | 12.0% | -10.7% |
| 营收同比 | 78.0% | — |
| 净利润同比 | -1.3% | — |
| 每股收益（稀释后） | $0.14 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收TGTXVNET
| Q4 25 | $192.6M | — | ||
| Q3 25 | $161.7M | $362.7M | ||
| Q2 25 | $141.1M | — | ||
| Q1 25 | $120.9M | $309.5M | ||
| Q4 24 | $108.2M | — | ||
| Q3 24 | $83.9M | $302.2M | ||
| Q2 24 | $73.5M | $274.4M | ||
| Q1 24 | $63.5M | $262.9M |
净利润TGTXVNET
| Q4 25 | $23.0M | — | ||
| Q3 25 | $390.9M | $-38.7M | ||
| Q2 25 | $28.2M | — | ||
| Q1 25 | $5.1M | $-2.4M | ||
| Q4 24 | $23.3M | — | ||
| Q3 24 | $3.9M | $-2.1M | ||
| Q2 24 | $6.9M | $-1.1M | ||
| Q1 24 | $-10.7M | $-22.0M |
毛利率TGTXVNET
| Q4 25 | 80.2% | — | ||
| Q3 25 | 82.6% | 20.9% | ||
| Q2 25 | 86.6% | — | ||
| Q1 25 | 87.1% | 25.2% | ||
| Q4 24 | 85.8% | — | ||
| Q3 24 | 88.9% | 23.2% | ||
| Q2 24 | 88.7% | 21.3% | ||
| Q1 24 | 91.4% | 21.6% |
营业利润率TGTXVNET
| Q4 25 | 26.2% | — | ||
| Q3 25 | 18.2% | 0.5% | ||
| Q2 25 | 24.7% | — | ||
| Q1 25 | 7.1% | 0.1% | ||
| Q4 24 | 27.7% | — | ||
| Q3 24 | 14.8% | 24.5% | ||
| Q2 24 | 12.0% | 0.2% | ||
| Q1 24 | -14.6% | 0.2% |
净利率TGTXVNET
| Q4 25 | 12.0% | — | ||
| Q3 25 | 241.7% | -10.7% | ||
| Q2 25 | 20.0% | — | ||
| Q1 25 | 4.2% | -0.8% | ||
| Q4 24 | 21.6% | — | ||
| Q3 24 | 4.6% | -0.7% | ||
| Q2 24 | 9.4% | -0.4% | ||
| Q1 24 | -16.9% | -8.4% |
每股收益（稀释后）TGTXVNET
| Q4 25 | $0.14 | — | ||
| Q3 25 | $2.43 | — | ||
| Q2 25 | $0.17 | — | ||
| Q1 25 | $0.03 | — | ||
| Q4 24 | $0.16 | — | ||
| Q3 24 | $0.02 | — | ||
| Q2 24 | $0.04 | — | ||
| Q1 24 | $-0.07 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $142.0M | $492.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $648.0M | $890.8M |
| 总资产 | $1.1B | $6.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资TGTXVNET
| Q4 25 | $142.0M | — | ||
| Q3 25 | $131.6M | $492.1M | ||
| Q2 25 | $251.9M | — | ||
| Q1 25 | $276.2M | $544.3M | ||
| Q4 24 | $311.0M | — | ||
| Q3 24 | $341.0M | $219.5M | ||
| Q2 24 | $217.3M | $247.2M | ||
| Q1 24 | $209.8M | $246.9M |
总债务TGTXVNET
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益TGTXVNET
| Q4 25 | $648.0M | — | ||
| Q3 25 | $607.2M | $890.8M | ||
| Q2 25 | $276.4M | — | ||
| Q1 25 | $237.3M | $927.8M | ||
| Q4 24 | $222.4M | — | ||
| Q3 24 | $192.2M | $902.9M | ||
| Q2 24 | $177.6M | $900.6M | ||
| Q1 24 | $160.1M | $895.1M |
总资产TGTXVNET
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.0B | $6.1B | ||
| Q2 25 | $702.6M | — | ||
| Q1 25 | $656.7M | $5.4B | ||
| Q4 24 | $577.7M | — | ||
| Q3 24 | $586.0M | $4.3B | ||
| Q2 24 | $401.2M | $4.0B | ||
| Q1 24 | $373.3M | $3.9B |
负债/权益比TGTXVNET
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.28× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.7M | $113.8M |
| 自由现金流经营现金流 - 资本支出 | $19.6M | $-193.1M |
| 自由现金流率自由现金流/营收 | 10.2% | -53.2% |
| 资本支出强度资本支出/营收 | 0.0% | 84.6% |
| 现金转化率经营现金流/净利润 | 0.85× | — |
| 过去12个月自由现金流最近4个季度 | $-25.0M | $-589.7M |
8季度趋势，按日历期对齐
经营现金流TGTXVNET
| Q4 25 | $19.7M | — | ||
| Q3 25 | $-23.2M | $113.8M | ||
| Q2 25 | $7.4M | — | ||
| Q1 25 | $-28.7M | $27.0M | ||
| Q4 24 | $-25.6M | — | ||
| Q3 24 | $-12.2M | $108.3M | ||
| Q2 24 | $5.5M | $55.8M | ||
| Q1 24 | $-8.2M | $37.1M |
自由现金流TGTXVNET
| Q4 25 | $19.6M | — | ||
| Q3 25 | $-23.2M | $-193.1M | ||
| Q2 25 | $7.4M | — | ||
| Q1 25 | $-28.7M | $-220.0M | ||
| Q4 24 | $-25.7M | — | ||
| Q3 24 | $-12.2M | $-95.0M | ||
| Q2 24 | — | $-81.6M | ||
| Q1 24 | — | $-102.2M |
自由现金流率TGTXVNET
| Q4 25 | 10.2% | — | ||
| Q3 25 | -14.4% | -53.2% | ||
| Q2 25 | 5.2% | — | ||
| Q1 25 | -23.8% | -71.1% | ||
| Q4 24 | -23.7% | — | ||
| Q3 24 | -14.6% | -31.4% | ||
| Q2 24 | — | -29.8% | ||
| Q1 24 | — | -38.9% |
资本支出强度TGTXVNET
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | 84.6% | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | 79.8% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | 67.3% | ||
| Q2 24 | 0.0% | 50.1% | ||
| Q1 24 | 0.0% | 53.0% |
现金转化率TGTXVNET
| Q4 25 | 0.85× | — | ||
| Q3 25 | -0.06× | — | ||
| Q2 25 | 0.26× | — | ||
| Q1 25 | -5.67× | — | ||
| Q4 24 | -1.10× | — | ||
| Q3 24 | -3.15× | — | ||
| Q2 24 | 0.80× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
TGTX
| Products | $189.1M | 98% |
| License | $3.5M | 2% |
VNET
暂无分部数据
